Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

This bulletin is predominantly aimed at GP surgeries, but the information is useful to know.

The latest bulletin contains information on the following:

• MHRA press release: If you take a GLP-1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you
• MHRA Report: Review of risk minimisation for disabling and potentially long lasting/irreversible side effects associated with fluoroquinolone antibiotics
• National Patient Safety Alert: Shortage of bumetanide 1mg tablets
• BNF update: Adrenaline auto-injectors for acute anaphylaxis
• MHRA drug safety update: IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older
• NPSA alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk
• MHRA drug safety update: Abrysvo▼ (Pfizer RSV vaccine) and Arexvy▼ (GSK RSVvaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults
• NHSE: Updated commissioning recommendations following the second national assessment of blood glucose and ketone meters, testing strips and lancets
• UK HSA: Vaccine update: issue 359, June 2025, childhood schedule changes special
• Serious Shortage Protocol
• FSRH CEU statement: Response to new study by Roland et al (2025). ‘Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial
• meningioma: national case-control study'
• Neonatal and Paediatric Pharmacy Group (NPPG): Labelling of dispensed oral medicines for children position statement
• Pharmacy First Translated posters

Download the bulletin here for more information and links:

• https://cpsc.org.uk/download_file/view/5253/3545